InvestorFest 22 nd September 2010

2 Disclaimer The information in this presentation does not constitute or form any part of, and should not be construed as, an offer or invitation to sell, or issue, or any solicitation of any offer to purchase, subscribe for or otherwise acquire any share or other securities in Brainjuicer Group PLC ("BrainJuicer") in any jurisdiction, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract therefore. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this presentation or their completeness. No representation or warranty, expressed or implied, is given on behalf of BrainJuicer or any of its respective directors, employees, agents or advisers as to the accuracy, completeness or fairness of the information or opinions contained herein or made in the presentation and, save in the case of fraud, no responsibility or liability is accepted (and all such liability is hereby excluded) for any such information or opinions. Readers of this presentation are reminded that any decision to acquire shares in BrainJuicer should not be made solely on the basis of information contained in this presentation. The information in this presentation may not be reproduced or further distributed to any other person or published, in whole or in part, for any purpose. The information in this presentation (or any copy of it) may not be sent or taken into the United States, Canada, Australia or Japan, nor may it be distributed to any US person (within the meaning of regulation S under the US Securities Act of 1933, as amended). Furthermore, this presentation is strictly only for persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 (SI 2001/1335), as amended, (the "FPO") or persons falling within paragraph 49 of the FPO (high net worth companies, unincorporated associations etc.) or to persons to whom it may otherwise be lawful for these materials to be communicated ("Permitted Recipients"). Any persons who are not Permitted Recipients should not stay for the remainder of this presentation and, in any event, must not act or rely upon the information contained in this presentation. By staying for the remainder of this presentation, each participant is deemed to confirm that they are a Permitted Recipient.

3 Agenda Introduction John Kearon - BrainJuicer Interim Results James Geddes - BrainJuicer Alex Batchelor - BrainJuicer Industry Perspective Simon Chadwick – Research World Magazine Federico Trovato – Philips Electronics Fr é d é ric-Charles Petit - Toluna John Kearon - BrainJuicer Q & A / Wrap Up

Interim Results September 2010

First Half – Key Financials  49% revenue growth to £7,208,000  119% growth in operating profit to £505,000  108% increase in profit before tax to £506,000  100% increase in fully diluted eps to 2.6p  0.6p interim dividend paid in March  687,000 shares bought back for £1,131,000  Period end cash £1,637,000 and no debt

First Half – Geographic growth  Strong UK recovery after flat 2009  Further good progress in US  Switzerland and Germany continue to build  Netherlands in transition RevenueEBIT £'000Change v 2009£'000Change v 2009 UK3,600+49%1,854+80% US & Canada1, % % Netherlands984-9%131-70% Switzerland374+19%71-53% Germany334+68%9264% TOTAL7,208+49%2,782+58%

7 Outlook  Strong H1, but profits heavily weighted to H2  Revenue visibility relatively poor  On track to meet market expectations

First Half – Operating Highlights  Increased investment in product development  Revenues from Juicy products up 55% to £3,758,000 –52% of revenue (H1 2009: 50%)  New technical platform nearing completion  Offices opened in China and Brazil  Appointment of Chief Operating Officer  Attracting talent: average headcount 79 (H1 2009: 63) –Young Researcher and ‘Research Superstar’ at 2010 Esomar

First Half – Product Development  BrainJuicer Labs investment paying off  Product development and validation continues apace  DigiViduals™  SatisTraction™

First Half – New Technical Platform  Total investment since 2006 £1.3m  Phased deployment during second half  Significantly increases capacity limits  Improves respondent experience  Reduces errors

11 Appendix

12 CFO James Geddes  20+ years' finance experience  CFO Iobox - sold to Telefonica  Executive Director Corporate Finance, MediaOne  Deloittes – Chartered Accountant Chairman Ken Ford  Previously Chief Executive of Teather & Greenwood  Previous directorships include Aberdeen Asset Management, Morgan Grenfell & Wedd Durlacher  36 years' City experience Non-Executive Director Simon Godfrey  Previously a director of RBL (now Research International)  Founded SGA Market Research  30 years of industry experience Non-Executive Director Mark Muth  Led Unilever Ventures’ investment in BrainJuicer in January 2003  20 years of experience in banking and venture capital CEO John Kearon  20+ years' experience  Unilever Research / Marketing  Publicis Planning Director  Founder Brand Genetics  E&Y Emerging Entrepreneur of Year Board of Directors COO Alex Batchelor  20+ years' marketing experience  CMO of TomTom  Marketing Director of Royal Mail  VP Global Brand of Orange  Current Chairman Marketing Society

13 Senior Managers UK MD Jim Rimmer  20+ years’ market research experience  General Manager at SGA Research International US MD Ari Popper  10+ years’ marketing and research experience  VP Millward Brown USA DE MD Jonathan Gable  20+ years’ experience in marketing & research  Colgate, General Mills & Dunkin Brands NL MD Carola-Verschoor  15+ years' marketing experience and innovation  Kraft Foods, Coca-Cola, Danone, Sara Lee CH MD Mark Johnson  10+ years’ experience in consumer insight and market research  Strong track record of innovation Labs MD Orlando Wood  13+ years’ market research experience  SGA, Research Intl  Developed FaceTrace EVP Mktg + BusDev Susan Casserly Griffin  20+ years' experience in operations, marketing and sales  American Stock Exchange, Thomas Publishing Company, Aberdeen Group and GMI China MD Han Zantingh  15+ years' marketing experience  5+ years in China  Pernod Ricard, Omicom, United Biscuits, Kimberly Clark Brazil MD Gabriel Aleixo  10+ years' experience in marketing and research  Beiersdorf, Philips